Two cancer research studies reveal essential role of neutrophils in immunotherapy
$ 14.99 · 4.9 (631) · In stock
Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
Scientists unravel tumor neutrophil complexity, discover
ASCO 2023: Immunotherapy for brain cancer metastases shows
Study identifies how microbiome may affect pancreatic cancer
Stress-tolerant cells drive tumour initiation in pancreatic cancer
WCLC 2023: Benmelstobart plus anlotinib and chemotherapy shows
New therapy harnesses patients' blood cells to fight tumours - ecancer
Tiago Biachi no LinkedIn: Two cancer research studies reveal
Surprise Finding Shows That Neutrophils Can Be Key Antitumor
Genetic signature may predict response to immunotherapy for non
WCLC 2022: Sugemalimab a safe and effective consolidation therapy
MicroRNA specifically kills cancer cells with common mutation
Retinol disruption and the role of vitamin a metabolism in colon